Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript
Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0.65387, expectations were $-0.8. Tandem Diabetes Care, Inc.
Tandem Diabetes Care Inc (TNDM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RiverPark Advisors Mitch Rubin | 10,153 | $359,518 | +1009% | 0.29% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.96 | 5,000 | Director | 19,962 | 2023-11-27 | Filing | |
| $15.39 | 6,200 | Officer | 11,860 | 2023-11-08 | Filing | |
| $15.44 | 1,935 | Officer | 1,935 | 2023-11-08 | Filing | |
| $21.45 | 1,000 | Director | 9,032 | 2023-09-15 | Filing | |
| $29.47 | 10,000 | Director | 12,205 | 2023-05-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $41.19 | 10,000 | Officer | 3,365 | 2023-03-03 | Filing | |
| $40.25 | 10,000 | Officer | 3,029 | 2022-12-16 | Filing | |
| $40.32 | 15,000 | Officer | 3,029 | 2022-12-15 | Filing | |
| $65.00 | 3,097 | Officer | 2,457 | 2022-06-08 | Filing | |
| $65.03 | 7,000 | Officer | 5,554 | 2022-06-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,245,653 | $273,486,415 | 0% | |
| 2. | 7,021,906 | $207,707,979 | 0% | |
| 3. | 6,384,111 | $188,842,003 | 0.03% | |
| 4. | 134,055,000 | $127,603,589 | 2.27% | |
| 5. | 2,977,274 | $88,067,758 | 0% |
News See All
Should You Invest in Tandem Diabetes Care (TNDM)?
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds released “The RiverPark/Next Century Growth Fund” Q4 2023 investor letter in partnership with Next...
Here are the Reasons to Invest in Tandem Diabetes Care (TNDM)
Next Century Growth Investors, LLC, an investment Management Company, released its “SMID Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2023 Earnings Call Transcript
Tandem Diabetes Care, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $-0.23. Tandem Diabetes Care, Inc.
12 Best Diabetes Stocks To Buy Now
In this article, we shall discuss the 12 best diabetes stocks to buy now.
15 Stocks with Consistent Growth
Growth companies and companies working on disruptive technologies were hit hardest by the market conditions as the cost of capital rose significantly in a short period of time.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to Tandem's Third Quarter 2023 Earnings Conference Call. [Operator Instructions].
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to Tandem Second Quarter 2023 Earnings Call. [Operator Instructions].
Hedge Fund and Insider Trading News: Michael Burry, Ken Griffin, Bridgewater Associates, Great Elm Group Inc (GEG), Luminar Technologies, Inc. (LAZR), and More
Michael Burry predicted the subprime mortgage crisis that preceded one of the worst market crashes in history, and he recently took a large position in this growth stock.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Tandem Diabetes Care First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
